speb/financial-data huggingface dataset:
Financial ratios for HBOR3.SA — annual report dated 2024-12-31
Total revenue: 205562459.54692557
Gross profit: 68955825.24271844
Operating income: 30712621.359223302
Net income: 26378640.77669903
Capital expenditures: 2191423.948220065
Operating cash flow: 85258252.42718446
Depreciation & amortization: 4976213.59223301
Net tangible assets: 234975728.1553398
Owner earnings: 29163430.42071197
Return on net tangible assets (%): 12.411252281100436
Capex to operating income (%): 7.1352553160102
Buffett classification: The Great
Stock price: 0.210016155088853
P/E ratio: 1.056453303754319
Shares outstanding: 132693612
Book value: 438704530.7443366
P/B ratio: 0.06352294139704834
Market cap (USD): 27867802.197092086
Debt to equity: 0.7346128679836263
Current ratio: 1.5233116795236161
Quick ratio: 0.8370457124415711
Effective tax rate (%): 15.165329253442408
Interest coverage ratio: 2.1094958655641505
COGS to revenue (%): 66.45504952864349
SG&A to revenue (%): 10.21650283065801
Free cash flow (dilution-adjusted): 83066828.4789644
Buyback yield (%): 0
Inventory turnover: 0.6403372842955887
Receivables turnover: 1.480819735000064
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9738934520702642
FCF margin (%): 40.40953229595017
Revenue growth (%): -21.87238281949073
Rule of 40 score: 18.53714947645944
Financial ratios for HBOR3.SA — quarterly report dated 2025-03-31
Total revenue: 51952777.777777776
Gross profit: 16378125
Operating income: 4309722.222222222
Net income: 6176736.111111111
Capital expenditures: 301041.6666666667
Operating cash flow: 9694618.055555556
Depreciation & amortization: 1193402.7777777778
Net tangible assets: 252936284.72222224
Owner earnings: 7069097.222222222
Return on net tangible assets (%): 2.794813417136095
Capex to operating income (%): 6.985175636480825
Buffett classification: The Great
Stock price: 0.296875
P/E ratio: 1.594426868570465
Shares outstanding: 132693612
Book value: 483714930.55555546
P/B ratio: 0.0814393221587267
Market cap (USD): 39393416.0625
Debt to equity: 0.617462936948487
Current ratio: 1.6098551946127082
Quick ratio: 0.7489747668645699
Effective tax rate (%): 14.100149693370032
Interest coverage ratio: 1.800145032632342
COGS to revenue (%): 68.47497727637277
SG&A to revenue (%): 11.053373790301022
Free cash flow (dilution-adjusted): 9393576.38888889
Buyback yield (%): 0
Retained earnings: 1314409.7222222222
Inventory turnover: 0.1557554492743929
Receivables turnover: 0.3855985547527836
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5111617934975541
FCF margin (%): 18.080989680799874
Rule of 40 score: 18.080989680799874
Financial ratios for HBOR3.SA — quarterly report dated 2025-06-30
Total revenue: 52108759.12408759
Gross profit: 16671350.364963502
Operating income: 3693065.6934306566
Net income: 3710401.459854014
Capital expenditures: 2287591.2408759124
Operating cash flow: -5676459.854014598
Depreciation & amortization: 243248.17518248173
Net tangible assets: 266157664.23357663
Owner earnings: 1666058.3941605836
Return on net tangible assets (%): 0.62596671749361
Capex to operating income (%): 61.942879731198744
Buffett classification: The Good
Stock price: 0.4635036496350365
P/E ratio: 6.220604599036828
Shares outstanding: 132693612
Book value: 514544525.5474452
P/B ratio: 0.11953090625115262
Market cap (USD): 61503973.44525547
Debt to equity: 0.6172190414312992
Current ratio: 2.310804839940409
Quick ratio: 0.809376112786599
Effective tax rate (%): 21.772083718067098
Interest coverage ratio: 1.2134548507015228
COGS to revenue (%): 68.00662567062152
SG&A to revenue (%): 20.322808836095195
Free cash flow (dilution-adjusted): -7964051.094890511
Buyback yield (%): 0
Retained earnings: 1681751.824817518
Inventory turnover: 0.09399474647405351
Receivables turnover: 0.38109295509990554
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.39785686510493723
FCF margin (%): -15.283517068455927
Revenue growth (%): 0.30023677843945845
Rule of 40 score: -14.983280290016468
Financial ratios for HBOR3.SA — quarterly report dated 2025-09-30
Total revenue: 43727443.60902256
Gross profit: 13284022.556390977
Operating income: 3525563.9097744357
Net income: 2445112.781954887
Capital expenditures: 1217105.2631578946
Operating cash flow: -1378195.4887218045
Depreciation & amortization: 644172.932330827
Net tangible assets: 274238157.8947368
Owner earnings: 1872180.451127819
Return on net tangible assets (%): 0.6826841550789712
Capex to operating income (%): 34.52228620174878
Buffett classification: The Good
Stock price: 0.7030075187969925
P/E ratio: 7.564280991931293
Shares outstanding: 132693612
Book value: 526982330.82706773
P/B ratio: 0.17701657432408813
Market cap (USD): 93284606.93233083
Debt to equity: 0.661767632847829
Current ratio: 1.8418811707753155
Quick ratio: 0.7553831006579252
Effective tax rate (%): 30.69053708439898
Interest coverage ratio: 1.1435888055606365
COGS to revenue (%): 69.62085715513905
SG&A to revenue (%): 20.566135064265143
Free cash flow (dilution-adjusted): -2595300.751879699
Buyback yield (%): 0
Retained earnings: 1819736.8421052631
Inventory turnover: 0.10004459906551985
Receivables turnover: 0.3499284739761099
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3681908687643757
FCF margin (%): -5.9351760306065415
Revenue growth (%): -16.084273845605193
Rule of 40 score: -22.019449876211734
Financial ratios for HBOR3.SA — quarterly report dated 2025-12-31
Total revenue: 56756934.30656934
Gross profit: 17091058.394160584
Operating income: 6686131.386861313
Net income: 4216970.802919707
Capital expenditures: 586678.8321167883
Operating cash flow: 2433759.124087591
Depreciation & amortization: 588686.1313868613
Net tangible assets: 263820437.95620435
Owner earnings: 4218978.10218978
Return on net tangible assets (%): 1.5991854667795502
Capex to operating income (%): 8.774563318777293
Buffett classification: The Great
Stock price: 0.4452423698384201
P/E ratio: 3.5700059666223014
Shares outstanding: 132693612
Book value: 508529744.52554727
P/B ratio: 0.11617967071802571
Market cap (USD): 59080818.26929982
Debt to equity: 0.669172220043255
Current ratio: 2.2502224385859795
Quick ratio: 0.7466671659676453
Effective tax rate (%): 22.3017954407908
Interest coverage ratio: 2.2117590245080287
COGS to revenue (%): 69.88727702972079
SG&A to revenue (%): 10.57043095798449
Free cash flow (dilution-adjusted): 1847080.2919708027
Buyback yield (%): 0
Inventory turnover: 0.10827592081281284
Receivables turnover: 0.4958272954657408
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7001924573754976
FCF margin (%): 3.2543693815347816
Revenue growth (%): 29.797055629518493
Rule of 40 score: 33.051425011053276
Financial ratios for HBOR3.SA — annual report dated 2025-12-31
Total revenue: 205923722.62773722
Gross profit: 63873540.145985395
Operating income: 18788503.649635036
Net income: 16793430.656934306
Capital expenditures: 4372262.773722627
Operating cash flow: 5609306.569343065
Depreciation & amortization: 2671897.8102189777
Net tangible assets: 263820437.95620435
Owner earnings: 15093065.693430658
Return on net tangible assets (%): 5.72096150334501
Capex to operating income (%): 23.270947251872066
Buffett classification: The Great
Stock price: 0.4452423698384201
P/E ratio: 3.51809106050075
Shares outstanding: 132693612
Book value: 508529744.52554727
P/B ratio: 0.11617967071802571
Market cap (USD): 59080818.26929982
Debt to equity: 0.669172220043255
Current ratio: 2.2502224385859795
Quick ratio: 0.7466671659676453
Effective tax rate (%): 20.610766045548658
Interest coverage ratio: 2.1889829067097546
COGS to revenue (%): 68.9819417933435
SG&A to revenue (%): 11.54270148219435
Free cash flow (dilution-adjusted): 1237043.795620438
Buyback yield (%): 0
Inventory turnover: 0.38775430911455616
Receivables turnover: 1.7989449872547192
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9675904913711413
FCF margin (%): 0.6007291339894476
Revenue growth (%): 0.17574370418017926
Rule of 40 score: 0.7764728381696269
Financial ratios for HPHA.DE — annual report dated 2021-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.820224719101123
Shares outstanding: 46784317
Market cap (USD): 272295238.2696629
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HPHA.DE — annual report dated 2022-11-30
Total revenue: 19086515.463917527
Gross profit: 14262453.608247424
Operating income: -18973021.649484538
Net income: -20311439.17525773
Capital expenditures: 586577.3195876289
Operating cash flow: -9138085.56701031
Depreciation & amortization: 780412.3711340206
Net tangible assets: 59479803.0927835
Owner earnings: -20117604.12371134
Return on net tangible assets (%): -33.822580233376975
Buffett classification: The Gruesome
Stock price: 5.896907216494845
Shares outstanding: 46784317
Book value: 68705576.2886598
P/B ratio: 4.015435011810218
Market cap (USD): 275882776.53608245
Debt to equity: 0.23978986744409422
Current ratio: 3.1459828547877122
Quick ratio: 3.0708055948635176
Interest coverage ratio: -21.912374699809376
COGS to revenue (%): 25.27471221653761
R&D to revenue (%): 142.46899089982023
SG&A to revenue (%): 26.01409101908186
Free cash flow (dilution-adjusted): -10340939.175257733
Buyback yield (%): 0
Retained earnings: -300406675.257732
Inventory turnover: 2.2282571428571427
Receivables turnover: 19.027667009249743
Capitalized R&D asset: 27192365.979381446
ROCI (R&D-adjusted, %): -0.827505942143836
FCF margin (%): -54.17929320208794
Rule of 40 score: -54.17929320208794
Financial ratios for HPHA.DE — annual report dated 2023-11-30
Total revenue: 10833969.23076923
Gross profit: 7259432.967032967
Operating income: -30875942.857142854
Net income: -22358775.824175823
Capital expenditures: 998103.2967032967
Operating cash flow: -37001976.92307692
Depreciation & amortization: 965934.0659340658
Net tangible assets: 44441534.06593406
Owner earnings: -22390945.054945055
Return on net tangible assets (%): -50.38292562476702
Buffett classification: The Gruesome
Stock price: 3.032967032967033
Shares outstanding: 46784317
Book value: 54219556.04395605
P/B ratio: 2.6170500364452254
Market cap (USD): 141895291.1208791
Debt to equity: 0.11818812546367236
Current ratio: 2.8639670299233804
Quick ratio: 2.3599350012594478
Interest coverage ratio: -36.89221113445378
COGS to revenue (%): 32.99378268109098
R&D to revenue (%): 284.7661689241166
SG&A to revenue (%): 53.23275022639415
Free cash flow (dilution-adjusted): -39112415.384615384
Buyback yield (%): 0
Retained earnings: -342572484.6153846
Inventory turnover: 0.3263597872980836
Receivables turnover: 10.070390194075587
Capitalized R&D asset: 49070364.32706469
ROCI (R&D-adjusted, %): -18.511422152367306
Rosenberg metric: -0.257536274942919
FCF margin (%): -361.0164894463
Revenue growth (%): -43.23757392358748
Rule of 40 score: -404.2540633698875
Financial ratios for HPHA.DE — annual report dated 2024-11-30
Total revenue: 7209744.210526316
Gross profit: 5335586.315789474
Operating income: -24167465.263157897
Net income: -20402100
Capital expenditures: 449996.8421052632
Operating cash flow: -31145027.368421055
Depreciation & amortization: 917074.7368421053
Net tangible assets: 23164984.210526317
Owner earnings: -19935022.105263155
Return on net tangible assets (%): -86.0567049132913
Buffett classification: The Gruesome
Stock price: 2.526315789473684
Shares outstanding: 46784317
Book value: 32490247.36842105
P/B ratio: 3.637767278180805
Market cap (USD): 118191958.7368421
Debt to equity: 0.0053143072730974985
Current ratio: 5.947752255359726
Quick ratio: 4.552153275056041
Interest coverage ratio: -162.25965398315148
COGS to revenue (%): 25.99479038383287
R&D to revenue (%): 318.9174241819222
SG&A to revenue (%): 98.37103498963464
Free cash flow (dilution-adjusted): -32603538.94736842
Buyback yield (%): 0
Retained earnings: -348550478.94736844
Inventory turnover: 0.1595242361795538
Receivables turnover: 24.117102112676058
Capitalized R&D asset: 52637102.31050068
ROCI (R&D-adjusted, %): -26.066168572988353
Rosenberg metric: -0.062358327900768486
FCF margin (%): -452.2149190780839
Revenue growth (%): -33.452421204500574
Rule of 40 score: -485.66734028258446
Financial ratios for HPHA.DE — quarterly report dated 2024-11-30
Total revenue: 1685775.7894736843
Gross profit: 1386837.8947368423
Operating income: -5640082.105263158
Net income: -5393098.947368422
Capital expenditures: 181315.7894736842
Operating cash flow: -7199117.894736842
Depreciation & amortization: 233227.36842105264
Net tangible assets: 23164984.210526317
Owner earnings: -5341187.3684210535
Return on net tangible assets (%): -23.057159546838733
Buffett classification: The Gruesome
Stock price: 2.526315789473684
Shares outstanding: 46784317
Book value: 32490247.36842105
P/B ratio: 3.637767278180805
Market cap (USD): 118191958.7368421
Debt to equity: 0.0053143072730974985
Current ratio: 5.947752255359726
Quick ratio: 4.552153275056041
Interest coverage ratio: -4902.175663311985
COGS to revenue (%): 17.732956933150255
R&D to revenue (%): 386.7300202873954
SG&A to revenue (%): 125.43248868083225
Free cash flow (dilution-adjusted): -7561837.894736842
Buyback yield (%): 0
Retained earnings: -348550478.94736844
Inventory turnover: 0.02544494220947944
Receivables turnover: 5.639038732394366
Capitalized R&D asset: 6519401.052631579
ROCI (R&D-adjusted, %): -2.086214778839836
FCF margin (%): -448.5672378233479
Rule of 40 score: -448.5672378233479
Financial ratios for HPHA.DE — quarterly report dated 2025-02-28
Total revenue: 1323250
Gross profit: 1277301.0416666667
Operating income: -8042359.375
Net income: -6185123.958333334
Capital expenditures: 98781.25
Operating cash flow: -8941410.416666668
Depreciation & amortization: 232978.125
Net tangible assets: 16833227.083333336
Owner earnings: -6050927.083333334
Return on net tangible assets (%): -35.94632837410236
Buffett classification: The Gruesome
Stock price: 2.875
Shares outstanding: 46784317
Book value: 26107008.333333336
P/B ratio: 5.152061456358621
Market cap (USD): 134504911.375
Debt to equity: 0.006060393744846929
Current ratio: 7.148959407661025
Quick ratio: 4.910428662482603
Interest coverage ratio: -5036.311154598826
COGS to revenue (%): 3.472432143082058
R&D to revenue (%): 520.3268467787643
SG&A to revenue (%): 126.58487625165313
Free cash flow (dilution-adjusted): -9207877.083333334
Buyback yield (%): 0
Retained earnings: -351104868.75
Inventory turnover: 0.0035449482578674006
Receivables turnover: 10.41297112972769
Capitalized R&D asset: 11253223.705263158
ROCI (R&D-adjusted, %): -9.302941351121854
Rosenberg metric: -0.016801674292757394
FCF margin (%): -695.8531708545879
Revenue growth (%): -21.504982556836243
Rule of 40 score: -717.3581534114242
Financial ratios for HPHA.DE — quarterly report dated 2025-05-31
Total revenue: 134673.86363636365
Gross profit: 76512.5
Operating income: -10129656.818181818
Net income: -7560805.681818182
Capital expenditures: 19513.636363636364
Operating cash flow: -6282263.636363637
Depreciation & amortization: 240281.81818181818
Net tangible assets: 10996712.5
Owner earnings: -7340037.5
Return on net tangible assets (%): -66.74756205547794
Buffett classification: The Gruesome
Stock price: 3.840909090909091
Shares outstanding: 46784317
Book value: 21044189.772727266
P/B ratio: 8.538903631735538
Market cap (USD): 179694308.47727272
Debt to equity: 0.00660007267175398
Current ratio: 7.738802899102692
Quick ratio: 5.725614909832724
Interest coverage ratio: -6773.630699088146
COGS to revenue (%): 43.18682338646393
R&D to revenue (%): 5773.328664365934
SG&A to revenue (%): 1544.5436365630774
Free cash flow (dilution-adjusted): -6360170.454545455
Buyback yield (%): 0
Retained earnings: -390584298.8636364
Inventory turnover: 0.003997793878896574
Receivables turnover: 9.20846930846931
Capitalized R&D asset: 14539667.870095694
ROCI (R&D-adjusted, %): -12.025918997441236
Rosenberg metric: -0.17440077000630577
FCF margin (%): -4722.646460725828
Revenue growth (%): -89.82249282929425
Rule of 40 score: -4812.4689535551215
Financial ratios for HPHA.DE — annual report dated 2025-11-30
Total revenue: 1694654.6511627908
Gross profit: 1377972.093023256
Operating income: -54703206.97674419
Net income: -49164419.76744186
Capital expenditures: 149595.3488372093
Operating cash flow: -36744456.97674419
Depreciation & amortization: 3276722.093023256
Net tangible assets: -22960608.139534883
Owner earnings: -46037293.02325582
Buffett classification: The Gruesome
Stock price: 3.3837209302325584
Shares outstanding: 46784317
Book value: -12695491.860465117
Market cap (USD): 158305072.6395349
Debt to equity: -0.010467000600744285
Current ratio: 2.527226307162212
Quick ratio: 1.7097328025513219
Interest coverage ratio: -9575.566456340322
COGS to revenue (%): 18.68714418729754
R&D to revenue (%): 2660.8246312104475
SG&A to revenue (%): 522.1200313159778
Free cash flow (dilution-adjusted): -37030941.86046512
Buyback yield (%): 0
Retained earnings: -434191112.7906977
Inventory turnover: 0.029719227411610653
Receivables turnover: 242.90050000000002
Capitalized R&D asset: 70678173.93461472
ROCI (R&D-adjusted, %): -41.76008781302512
Rosenberg metric: -0.17212159163088744
FCF margin (%): -2185.1615510603447
Revenue growth (%): -76.49494071247945
Rule of 40 score: -2261.656491772824
Financial ratios for HPHA.DE — quarterly report dated 2025-11-30
Total revenue: 24930.232558139534
Gross profit: -80116.27906976745
Operating income: -23606194.18604651
Net income: -24682769.76744186
Capital expenditures: 50884.88372093024
Operating cash flow: -7886605.813953488
Depreciation & amortization: 2521436.0465116277
Net tangible assets: -22960608.139534883
Owner earnings: -22212218.604651164
Buffett classification: The Gruesome
Stock price: 3.3837209302325584
Shares outstanding: 46784317
Book value: -12695491.860465117
Market cap (USD): 158305072.6395349
Debt to equity: -0.010467000600744285
Current ratio: 2.527226307162212
Quick ratio: 1.7097328025513219
Interest coverage ratio: -21923.679265658746
COGS to revenue (%): 421.36194029850753
R&D to revenue (%): 82726.11473880598
SG&A to revenue (%): 12193.330223880597
Free cash flow (dilution-adjusted): -7578429.0697674425
Buyback yield (%): 0
Retained earnings: -434191112.7906977
Inventory turnover: 0.009858140549978175
Receivables turnover: 3.5733333333333333
Capitalized R&D asset: 28105297.43842495
ROCI (R&D-adjusted, %): -24.814924686033677
Rosenberg metric: -0.02014475366736533
FCF margin (%): -30398.549440298513
Revenue growth (%): -81.48844038108663
Rule of 40 score: -30480.0378806796
Financial ratios for HPHA.DE — quarterly report dated 2026-02-28
Total revenue: 3566735.294117647
Gross profit: 3126494.117647059
Operating income: -6350132.94117647
Net income: -5029864.705882353
Capital expenditures: 689455.2941176471
Operating cash flow: -7350495.294117647
Depreciation & amortization: 83874.11764705883
Net tangible assets: -28203523.529411767
Owner earnings: -5635445.882352941
Buffett classification: The Gruesome
Stock price: 3.541176470588235
Shares outstanding: 46784317
Book value: -17830169.41176471
Market cap (USD): 165671522.55294117
Debt to equity: -0.005107272247883362
Current ratio: 2.3950681498325146
Quick ratio: 1.3273633733809964
Interest coverage ratio: -7591.57946554149
COGS to revenue (%): 12.342973059891646
R&D to revenue (%): 200.31843257551395
SG&A to revenue (%): 51.821982534695586
Free cash flow (dilution-adjusted): -7404055.294117647
Buyback yield (%): 0
Retained earnings: -444329108.2352941
Inventory turnover: 0.038811025295385604
Receivables turnover: 47.31008707593396
Capitalized R&D asset: 23528587.18006156
ROCI (R&D-adjusted, %): -22.505258238669786
Rosenberg metric: 0.15548096897791666
FCF margin (%): -207.5863411094344
Revenue growth (%): 14206.867317822653
Rule of 40 score: 13999.280976713218
Financial ratios for HYPE3.SA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.143859649122807
Shares outstanding: 703992255
Market cap (USD): 2917245098.7894735
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HYPE3.SA — annual report dated 2022-12-31
Total revenue: 1429233901.5151515
Gross profit: 901803787.8787879
Operating income: 465784090.9090909
Net income: 321666477.27272725
Capital expenditures: 97641666.66666666
Operating cash flow: 386135037.8787879
Depreciation & amortization: 32026704.545454543
Net tangible assets: -85172727.27272727
Owner earnings: 256051515.15151516
Return on net tangible assets (%): -300.62617853203835
Capex to operating income (%): 20.962859954296682
Buffett classification: The Great
Stock price: 7.379506641366224
P/E ratio: 16.15062771007427
Shares outstanding: 703992255
Book value: 2018075946.9696965
P/B ratio: 2.574291383356394
Market cap (USD): 5195115521.242885
Debt to equity: 0.9085470042957398
Current ratio: 1.6324982383429207
Quick ratio: 1.2122302061894736
Effective tax rate (%): -5.918177845750491
Interest coverage ratio: 2.4940522187809937
COGS to revenue (%): 36.90299488958576
R&D to revenue (%): 2.112158783942711
SG&A to revenue (%): 24.554794997054866
Free cash flow (dilution-adjusted): 95542045.45454544
Buyback yield (%): 0.3171794898826183
Inventory turnover: 1.26814837280087
Receivables turnover: 2.980641356763933
Capitalized R&D asset: 30187689.39393939
ROCI (R&D-adjusted, %): 13.727255232747792
FCF margin (%): 6.684843212385316
Rule of 40 score: 6.684843212385316
Financial ratios for HYPE3.SA — annual report dated 2023-12-31
Total revenue: 1631888247.4226806
Gross profit: 1030009072.1649486
Operating income: 515034639.17525774
Net income: 340319587.628866
Capital expenditures: 94883092.78350516
Operating cash flow: 494019175.257732
Depreciation & amortization: 49136494.84536083
Net tangible assets: 14903917.525773197
Owner earnings: 294572989.6907217
Return on net tangible assets (%): 1976.480272259421
Capex to operating income (%): 18.42266239324109
Buffett classification: The Great
Stock price: 6.569358178053831
P/E ratio: 13.589512463544525
Shares outstanding: 703992255
Book value: 2374819175.257732
P/B ratio: 1.9474229136493706
Market cap (USD): 4624777277.670808
Debt to equity: 0.864902399948324
Current ratio: 1.7393099747730305
Quick ratio: 1.2673849907713561
Effective tax rate (%): -9.383262392553702
Interest coverage ratio: 2.2122129143275155
COGS to revenue (%): 36.88237697699635
R&D to revenue (%): 2.141671819553037
SG&A to revenue (%): 25.207242056447672
Free cash flow (dilution-adjusted): 316924536.08247423
Buyback yield (%): 0.39434832995780544
Inventory turnover: 1.331876037707182
Receivables turnover: 2.9955415030055113
Capitalized R&D asset: 55175442.61558889
ROCI (R&D-adjusted, %): 12.726524037321575
Rosenberg metric: 4.246939294131592
FCF margin (%): 19.420725443853666
Revenue growth (%): 14.17922886468704
Rule of 40 score: 33.5999543085407
Financial ratios for HYPE3.SA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.414364640883978
Shares outstanding: 703992255
Market cap (USD): 3107678517.928177
Buyback yield (%): 0.07850216260749754
Retained earnings: 130119337.01657459
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HYPE3.SA — quarterly report dated 2024-12-31
Total revenue: 244496925.56634304
Gross profit: 127255663.43042071
Operating income: 8286407.766990292
Net income: 12873462.783171521
Capital expenditures: 26203398.058252428
Operating cash flow: 112977022.65372169
Depreciation & amortization: 12115533.980582524
Net tangible assets: 49421682.84789644
Owner earnings: -1214401.2944983803
Return on net tangible assets (%): -2.4572236810225685
Capex to operating income (%): 316.2214411247803
Buffett classification: The Gruesome
Stock price: 2.7140549273021
P/E ratio: 37.10488934964223
Shares outstanding: 703992255
Book value: 1958223139.158576
P/B ratio: 0.975718042677332
Market cap (USD): 1910673648.4652665
Debt to equity: 0.77652516534911
Current ratio: 1.6958697369195814
Quick ratio: 1.2038502693340858
Interest coverage ratio: 0.2261196698944245
COGS to revenue (%): 47.95203942313356
R&D to revenue (%): 1.4732715151844056
SG&A to revenue (%): 39.784618174429895
Free cash flow (dilution-adjusted): 68652750.8090615
Buyback yield (%): 0
Inventory turnover: 0.3737496131228722
Receivables turnover: 0.6717727927286274
Capitalized R&D asset: 3602103.5598705504
ROCI (R&D-adjusted, %): 0.31999344742716557
FCF margin (%): 28.07918776485102
Rule of 40 score: 28.07918776485102
Financial ratios for HYPE3.SA — annual report dated 2024-12-31
Total revenue: 1204282524.2718446
Gross profit: 708899514.5631068
Operating income: 290577508.0906149
Net income: 216988673.13915858
Capital expenditures: 69480906.14886732
Operating cash flow: 410938349.51456314
Depreciation & amortization: 45478155.33980583
Net tangible assets: 49421682.84789644
Owner earnings: 192985922.33009708
Return on net tangible assets (%): 390.48836706763666
Capex to operating income (%): 23.911315987746754
Buffett classification: The Great
Stock price: 2.7140549273021
P/E ratio: 8.805407309163638
Shares outstanding: 703992255
Book value: 1958223139.158576
P/B ratio: 0.975718042677332
Market cap (USD): 1910673648.4652665
Debt to equity: 0.77652516534911
Current ratio: 1.6958697369195814
Quick ratio: 1.2038502693340858
Effective tax rate (%): -36.12625327040004
Interest coverage ratio: 1.8509781245200598
COGS to revenue (%): 41.135115699554426
R&D to revenue (%): 1.9553465208977778
SG&A to revenue (%): 28.56361050221795
Free cash flow (dilution-adjusted): 280603398.05825245
Buyback yield (%): 0.4726217324936605
Inventory turnover: 1.5792154131847727
Receivables turnover: 3.308852382051155
Capitalized R&D asset: 56926126.723634616
ROCI (R&D-adjusted, %): 8.385962667970295
Rosenberg metric: -9.187765355615332
FCF margin (%): 23.300462507991305
Revenue growth (%): -26.20312535654168
Rule of 40 score: -2.9026628485503743
Financial ratios for HYPE3.SA — quarterly report dated 2025-03-31
Total revenue: 187657291.6666667
Gross profit: 88587326.3888889
Operating income: -39041493.05555556
Net income: -24296354.166666668
Capital expenditures: 25588020.833333336
Operating cash flow: 98950347.22222222
Depreciation & amortization: 13457986.111111112
Net tangible assets: -14552430.555555556
Owner earnings: -36426388.888888896
Buffett classification: The Gruesome
Stock price: 3.1684027777777777
Shares outstanding: 703992255
Book value: 2038651562.5
P/B ratio: 1.0941207694858555
Market cap (USD): 2230531016.2760415
Debt to equity: 0.7930366213437822
Current ratio: 1.2626241952290753
Quick ratio: 0.8020988138230623
Interest coverage ratio: -0.944020922363925
COGS to revenue (%): 52.79302733077621
R&D to revenue (%): 4.2824260388969995
SG&A to revenue (%): 52.508266213713306
Free cash flow (dilution-adjusted): 60456423.61111111
Buyback yield (%): 0.17970309778634697
Retained earnings: -24296354.166666668
Inventory turnover: 0.2658408177925694
Receivables turnover: 0.8724371443561081
Capitalized R&D asset: 10449694.107335493
ROCI (R&D-adjusted, %): -1.0184691994271033
Rosenberg metric: -10.734932074779508
FCF margin (%): 32.21639994597125
Revenue growth (%): -23.247586352268137
Rule of 40 score: 8.96881359370311
Financial ratios for HYPE3.SA — quarterly report dated 2025-06-30
Total revenue: 393054197.0802919
Gross profit: 236329562.04379562
Operating income: 117399452.55474451
Net income: 77862956.20437956
Capital expenditures: 28679744.525547445
Operating cash flow: 80798357.66423357
Depreciation & amortization: 14369343.065693429
Net tangible assets: 16970985.401459854
Owner earnings: 63552554.74452554
Return on net tangible assets (%): 374.47769378823875
Capex to operating income (%): 24.429197838187363
Buffett classification: The Great
Stock price: 4.726277372262773
P/E ratio: 50.07916042864651
Shares outstanding: 703992255
Book value: 2188756386.861314
P/B ratio: 1.5201612591641838
Market cap (USD): 3327262665.0547442
Debt to equity: 0.7388171215114405
Current ratio: 1.2646768579666903
Quick ratio: 0.7895584057943252
Effective tax rate (%): 1.819840827292543
Interest coverage ratio: 2.5411036547553687
COGS to revenue (%): 39.87354319091042
R&D to revenue (%): 1.83166917138245
SG&A to revenue (%): 24.97408234316974
Free cash flow (dilution-adjusted): 39796897.810218975
Buyback yield (%): 0
Inventory turnover: 0.4073642800496321
Receivables turnover: 1.3564620872241968
Capitalized R&D asset: 13772457.493390696
ROCI (R&D-adjusted, %): 3.26224315290351
Rosenberg metric: 18.38439537195149
FCF margin (%): 10.125040797386367
Revenue growth (%): 109.45319714965791
Rule of 40 score: 119.57823794704427
Financial ratios for HYPE3.SA — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.120300751879699
P/E ratio: 43.65829301060837
Shares outstanding: 703992255
Market cap (USD): 2900659817.593985
Buyback yield (%): 0
Capitalized R&D asset: 7475607.170012165
Rule of 40 score: 0
Financial ratios for HYPE3.SA — annual report dated 2025-12-31
Total revenue: 1404955656.9343064
Gross profit: 829472080.2919707
Operating income: 317162226.27737224
Net income: 218133029.19708028
Capital expenditures: 95477372.26277372
Operating cash flow: 469786678.8321167
Depreciation & amortization: 57887408.759124085
Net tangible assets: 84864781.02189781
Owner earnings: 180543065.69343063
Return on net tangible assets (%): 212.74203918212527
Capex to operating income (%): 30.10363919544271
Buffett classification: The Good
Stock price: 4.131059245960503
P/E ratio: 13.332385860166017
Shares outstanding: 703992255
Book value: 2285469708.0291967
P/B ratio: 1.272488409662694
Market cap (USD): 2908233714.102334
Debt to equity: 0.7455421724071798
Current ratio: 1.4712750065860416
Quick ratio: 0.9655117640204846
Effective tax rate (%): -32.30337983696878
Interest coverage ratio: 1.6653242883286863
COGS to revenue (%): 40.960977935636336
R&D to revenue (%): 1.7499578200574426
SG&A to revenue (%): 29.51094515932069
Free cash flow (dilution-adjusted): 319724087.5912409
Buyback yield (%): 0.14486932964504984
Inventory turnover: 1.5167787623558564
Receivables turnover: 4.5601340233907175
Capitalized R&D asset: 51896619.93989238
ROCI (R&D-adjusted, %): 8.067976231684442
Rosenberg metric: 5.120311533364342
FCF margin (%): 22.756881045548237
Revenue growth (%): 16.663293589168077
Rule of 40 score: 39.42017463471632
Financial ratios for HYPE3.SA — quarterly report dated 2025-12-31
Total revenue: 408223905.109489
Gross profit: 251482116.78832114
Operating income: 118666605.83941604
Net income: 82297262.77372262
Capital expenditures: 17687226.27737226
Operating cash flow: 129219525.54744525
Depreciation & amortization: 14960948.905109487
Net tangible assets: 84864781.02189781
Owner earnings: 79570985.40145986
Return on net tangible assets (%): 93.76208180037372
Capex to operating income (%): 14.904973604206104
Buffett classification: The Great
Stock price: 4.131059245960503
P/E ratio: 21.405498203209888
Shares outstanding: 703992255
Book value: 2285469708.0291967
P/B ratio: 1.272488409662694
Market cap (USD): 2908233714.102334
Debt to equity: 0.7455421724071798
Current ratio: 1.4712750065860416
Quick ratio: 0.9655117640204846
Effective tax rate (%): -2.3815649568426736
Interest coverage ratio: 2.4189298268454626
COGS to revenue (%): 38.396033735243506
R&D to revenue (%): 1.89440012301822
SG&A to revenue (%): 26.29666433772435
Free cash flow (dilution-adjusted): 93723357.66423358
Buyback yield (%): 0
Inventory turnover: 0.4131179852018299
Receivables turnover: 1.3249925075309679
Capitalized R&D asset: 10109213.503649635
ROCI (R&D-adjusted, %): 3.1531652684448823
FCF margin (%): 22.958811694061914
Rule of 40 score: 22.958811694061914
Financial ratios for ISHANCH.NS — annual report dated 2025-03-31
Total revenue: 11862239.887771802
Gross profit: 2834837.502922609
Operating income: 496703.29670329666
Net income: 126841.24386252045
Capital expenditures: 4926490.53074585
Operating cash flow: 1356815.5249006313
Depreciation & amortization: 288286.18190320313
Net tangible assets: 12058452.18611176
Owner earnings: -4511363.104980126
Return on net tangible assets (%): -37.412455888626056
Capex to operating income (%): 991.8376953492751
Buffett classification: The Gruesome
Stock price: 0.46364803360952267
P/E ratio: 99.80688924546621
Shares outstanding: 27304397
Book value: 12142681.786298806
P/B ratio: 1.0425728188173589
Market cap (USD): 12659629.97794375
Debt to equity: 0.8866287661803146
Current ratio: 0.9948867579779322
Quick ratio: 0.5374389494869374
Effective tax rate (%): 48.791768925807055
Interest coverage ratio: 0.8284037512916999
COGS to revenue (%): 76.10200493546836
SG&A to revenue (%): 3.4569959869754094
Free cash flow (dilution-adjusted): -3569675.0058452184
Buyback yield (%): 0
Retained earnings: 5606394.669160626
Inventory turnover: 2.1736366988591422
Receivables turnover: 8.47225028597193
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.945764596746126
FCF margin (%): -30.092756845400004
Revenue growth (%): 29.021309062904322
Rule of 40 score: -1.0714477824956816
Financial ratios for ISHANCH.NS — quarterly report dated 2025-03-31
Total revenue: 1955938.7421089548
Gross profit: 557540.3320084171
Operating income: -35959.784895955105
Net income: -135842.88052373158
Capital expenditures: 0
Depreciation & amortization: 70890.81131634323
Net tangible assets: 12058452.18611176
Owner earnings: -64952.069207388355
Return on net tangible assets (%): -0.5386435025400396
Buffett classification: The Gruesome
Stock price: 0.46364803360952267
Shares outstanding: 27304397
Book value: 12142681.786298806
P/B ratio: 1.0425728188173589
Market cap (USD): 12659629.97794375
Debt to equity: 0.8866287661803146
Current ratio: 0.9948867579779322
Quick ratio: 0.5374389494869374
Interest coverage ratio: -0.23832029131479043
COGS to revenue (%): 71.49500032872913
Buyback yield (%): 0
Retained earnings: 5606394.669160626
Inventory turnover: 0.33670927407891144
Receivables turnover: 1.39697078494076
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.21326426048745725
Revenue growth (%): -20.795264384521918
Rule of 40 score: -20.795264384521918
Financial ratios for ISHANCH.NS — quarterly report dated 2025-06-30
Total revenue: 1905956.0028083315
Gross profit: 538064.5916218114
Operating income: 143295.1088228411
Net income: 35572.19751930728
Capital expenditures: 0
Depreciation & amortization: 70793.35361572666
Owner earnings: 106365.55113503395
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6779780014041658
P/E ratio: 130.10006267927633
Shares outstanding: 27304397
Market cap (USD): 18511780.5076059
Effective tax rate (%): 25.160019694731663
Interest coverage ratio: 0.9693659463310379
COGS to revenue (%): 71.76930680304267
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.5554348009248153
Rule of 40 score: -2.5554348009248153
Financial ratios for ISHANCH.NS — quarterly report dated 2025-09-30
Total revenue: 760000
Gross profit: 84069.89853438556
Operating income: -257790.30439684328
Net income: -408669.6730552424
Capital expenditures: 0
Depreciation & amortization: 67835.40022547914
Net tangible assets: 15751510.7102593
Owner earnings: -340834.27282976324
Return on net tangible assets (%): -2.163819579589725
Buffett classification: The Gruesome
Stock price: 0.7020293122886133
Shares outstanding: 27304397
Book value: 15823449.830890642
P/B ratio: 1.2113974672542287
Market cap (USD): 19168487.048365276
Debt to equity: 0.6287815096114112
Current ratio: 1.0964939134785672
Quick ratio: 0.6992850230096187
Interest coverage ratio: -1.4620204603580562
COGS to revenue (%): 88.93817124547559
Buyback yield (%): 0
Inventory turnover: 0.24843266358102706
Receivables turnover: 1.0396829068924567
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2851012889791857
Revenue growth (%): -60.12499769773396
Rule of 40 score: -60.12499769773396
Financial ratios for ISHANCH.NS — quarterly report dated 2025-12-31
Total revenue: 2081597.4156176897
Gross profit: 116854.18291188593
Operating income: -396234.8223237162
Net income: -585095.2433997996
Capital expenditures: 0
Depreciation & amortization: 174935.94742118748
Owner earnings: -410159.2959786121
Buffett classification: The Gruesome
Stock price: 0.7313133563551298
Shares outstanding: 27304397
Market cap (USD): 19968070.213322937
Interest coverage ratio: -2.668417104276069
COGS to revenue (%): 94.3863216760763
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 173.89439679180128
Rule of 40 score: 173.89439679180128
Financial ratios for JCS.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.045112781954887216
Shares outstanding: 352343439
Market cap (USD): 15895192.736842105
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JCS.AX — annual report dated 2022-06-30
Total revenue: 10530374.48275862
Gross profit: 8992826.206896553
Operating income: 29561.37931034483
Net income: -45786.206896551725
Capital expenditures: 86702.75862068965
Depreciation & amortization: 748964.827586207
Net tangible assets: 1257170.3448275863
Owner earnings: 616475.8620689656
Capex to operating income (%): 293.29740574841355
Buffett classification: The Gruesome
Stock price: 0.041379310344827586
Shares outstanding: 352343439
Book value: 3449275.1724137934
P/B ratio: 4.226896313448362
Market cap (USD): 14579728.510344828
Debt to equity: 0.29486654767448395
Current ratio: 1.1391865951907685
Quick ratio: 1.1391865951907685
Effective tax rate (%): 115.98815157316767
Interest coverage ratio: 0.44751156259461494
COGS to revenue (%): 14.60107879714531
SG&A to revenue (%): 62.87145173407397
Free cash flow (dilution-adjusted): 634262.7586206896
Buyback yield (%): 0
Retained earnings: -9811633.793103449
Receivables turnover: 7.950787942788231
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5515112455464091
FCF margin (%): 6.023173816459878
Rule of 40 score: 6.023173816459878
Financial ratios for JCS.AX — annual report dated 2023-06-30
Total revenue: 10859031.78807947
Gross profit: 9459511.258278146
Operating income: 235491.3907284768
Net income: -225745.03311258278
Capital expenditures: 24790.066225165563
Depreciation & amortization: 833223.8410596027
Net tangible assets: 1420431.7880794702
Owner earnings: 582688.7417218543
Capex to operating income (%): 10.526952237395667
Buffett classification: The Great
Stock price: 0.026490066225165563
Shares outstanding: 352343439
Book value: 3133375.496688742
P/B ratio: 2.9787687568808954
Market cap (USD): 9333601.033112584
Debt to equity: 0.21275449935822335
Current ratio: 1.2958696103769831
Quick ratio: 1.2958696103769831
Effective tax rate (%): 217.24634889624195
Interest coverage ratio: 6.6312099060122325
COGS to revenue (%): 12.888078395144323
SG&A to revenue (%): 59.2359715457661
Free cash flow (dilution-adjusted): -121737.08609271522
Buyback yield (%): 0
Retained earnings: -9647512.582781456
Receivables turnover: 11.679364018858342
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.942477084584558
FCF margin (%): -1.12106759118573
Revenue growth (%): 3.12104100247299
Rule of 40 score: 1.9999734112872602
Financial ratios for JCS.AX — annual report dated 2024-06-30
Total revenue: 8492621.333333334
Gross profit: 7693630.666666667
Operating income: -940185.3333333334
Net income: -1269702
Capital expenditures: 3436.6666666666665
Depreciation & amortization: 659302
Net tangible assets: -114763.33333333333
Owner earnings: -613836.6666666666
Buffett classification: The Gruesome
Stock price: 0.013333333333333334
Shares outstanding: 352343439
Book value: 1517985.3333333335
P/B ratio: 3.0948339333976875
Market cap (USD): 4697912.5200000005
Debt to equity: 0.29220572179441345
Current ratio: 0.8201583407102802
Quick ratio: 0.8201583407102802
Interest coverage ratio: -27.924085220972596
COGS to revenue (%): 9.408057127551979
SG&A to revenue (%): 79.14044913655242
Free cash flow (dilution-adjusted): -1139199.3333333333
Buyback yield (%): 0
Retained earnings: -11364598.666666666
Receivables turnover: 9.361141831719003
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -36.24007063621936
FCF margin (%): -13.413989492996741
Revenue growth (%): -21.79209436833834
Rule of 40 score: -35.20608386133508
Financial ratios for KSS — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 44.19
Shares outstanding: 113399993
Market cap (USD): 5011145690.67
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KSS — annual report dated 2023-01-31
Total revenue: 18098000000
Gross profit: 6641000000
Operating income: 246000000
Net income: -19000000
Capital expenditures: 826000000
Operating cash flow: 282000000
Depreciation & amortization: 808000000
Net tangible assets: 3763000000
Owner earnings: -37000000
Return on net tangible assets (%): -0.9832580387988307
Capex to operating income (%): 335.7723577235773
Buffett classification: The Gruesome
Stock price: 25.31
Shares outstanding: 113399993
Book value: 3763000000
P/B ratio: 0.7627302213207546
Market cap (USD): 2870153822.83
Debt to equity: 2.010629816635663
Current ratio: 1.1993579454253611
Quick ratio: 0.17560192616372391
Interest coverage ratio: 0.8092105263157895
COGS to revenue (%): 63.30533760636534
SG&A to revenue (%): 30.87081445463587
Free cash flow (dilution-adjusted): -574000000
Buyback yield (%): 23.657268631355073
Retained earnings: 13995000000
Inventory turnover: 3.5926622765757292
Receivables turnover: 86.18095238095238
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1905609973285842
FCF margin (%): -3.1716211736103435
Rule of 40 score: -3.1716211736103435
Financial ratios for KSS — annual report dated 2024-01-31
Total revenue: 17476000000
Gross profit: 6978000000
Operating income: 717000000
Net income: 317000000
Capital expenditures: 551000000
Operating cash flow: 1168000000
Depreciation & amortization: 749000000
Net tangible assets: 3893000000
Owner earnings: 515000000
Return on net tangible assets (%): 13.228872334960185
Capex to operating income (%): 76.84797768479777
Buffett classification: The Gruesome
Stock price: 21.95
P/E ratio: 7.852144625709778
Shares outstanding: 113399993
Book value: 3893000000
P/B ratio: 0.6393860381068585
Market cap (USD): 2489129846.35
Debt to equity: 1.8946827639352684
Current ratio: 1.3055130168453293
Quick ratio: 0.2029096477794793
Effective tax rate (%): 15.013404825737265
Interest coverage ratio: 2.0843023255813953
COGS to revenue (%): 60.07095445181964
SG&A to revenue (%): 31.540398260471502
Free cash flow (dilution-adjusted): 549000000
Buyback yield (%): 0.6427949117826061
Retained earnings: 2934000000
Inventory turnover: 3.645138888888889
Receivables turnover: 104.64670658682634
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.291129244538037
FCF margin (%): 3.1414511329823758
Revenue growth (%): -3.4368438501491876
Rule of 40 score: -0.2953927171668118
Financial ratios for KSS — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.85
Shares outstanding: 113399993
Market cap (USD): 1910789882.0500002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KSS — quarterly report dated 2025-01-31
Total revenue: 5397000000
Gross profit: 1924000000
Operating income: 202000000
Net income: 48000000
Capital expenditures: 99000000
Operating cash flow: 596000000
Depreciation & amortization: 183000000
Net tangible assets: 3802000000
Owner earnings: 132000000
Return on net tangible assets (%): 3.4718569174118885
Capex to operating income (%): 49.00990099009901
Buffett classification: The Good
Stock price: 12.46
P/E ratio: 7.3591870457291675
Shares outstanding: 113399993
Book value: 3802000000
P/B ratio: 0.37163701019989476
Market cap (USD): 1412963912.7800002
Debt to equity: 1.8829563387690689
Current ratio: 1.082082401788566
Quick ratio: 0.14148834238262537
Effective tax rate (%): 7.6923076923076925
Interest coverage ratio: 2.72972972972973
COGS to revenue (%): 64.35056512877524
SG&A to revenue (%): 28.515842134519175
Free cash flow (dilution-adjusted): 492000000
Buyback yield (%): 0
Retained earnings: 1008000000
Inventory turnover: 1.1792869269949067
Receivables turnover: 33.943396226415096
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9370924434215575
FCF margin (%): 9.116175653140633
Rule of 40 score: 9.116175653140633
Financial ratios for KSS — annual report dated 2025-01-31
Total revenue: 16221000000
Gross profit: 6560000000
Operating income: 509000000
Net income: 109000000
Capital expenditures: 460000000
Operating cash flow: 648000000
Depreciation & amortization: 743000000
Net tangible assets: 3802000000
Owner earnings: 392000000
Return on net tangible assets (%): 10.310362966859547
Capex to operating income (%): 90.37328094302553
Buffett classification: The Gruesome
Stock price: 12.46
P/E ratio: 12.962971676880734
Shares outstanding: 113399993
Book value: 3802000000
P/B ratio: 0.37163701019989476
Market cap (USD): 1412963912.7800002
Debt to equity: 1.8829563387690689
Current ratio: 1.082082401788566
Quick ratio: 0.14148834238262537
Effective tax rate (%): 4.385964912280701
Interest coverage ratio: 1.5956112852664577
COGS to revenue (%): 59.55859688058689
SG&A to revenue (%): 32.72301337772024
Free cash flow (dilution-adjusted): 152000000
Buyback yield (%): 0.7077321585888945
Retained earnings: 1008000000
Inventory turnover: 3.2804753820033956
Receivables turnover: 102.01886792452831
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.88108937476026
FCF margin (%): 0.9370569015473769
Revenue growth (%): -7.181277180132753
Rule of 40 score: -6.2442202785853755
Financial ratios for KSS — quarterly report dated 2025-04-30
Total revenue: 3233000000
Gross profit: 1399000000
Operating income: 60000000
Net income: -15000000
Capital expenditures: 110000000
Operating cash flow: -92000000
Depreciation & amortization: 175000000
Net tangible assets: 3779000000
Owner earnings: 50000000
Capex to operating income (%): 183.33333333333331
Buffett classification: The Gruesome
Stock price: 6.41
Shares outstanding: 113399993
Book value: 3779000000
P/B ratio: 0.1923508746043927
Market cap (USD): 726893955.13
Debt to equity: 1.9505160095263296
Current ratio: 1.0914634146341464
Quick ratio: 0.1350609756097561
Interest coverage ratio: 0.7894736842105263
COGS to revenue (%): 56.72749768017321
SG&A to revenue (%): 36.00371172285803
Free cash flow (dilution-adjusted): -211000000
Buyback yield (%): 0.5502865956953277
Retained earnings: 979000000
Inventory turnover: 0.5846350015938795
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5792064871126557
FCF margin (%): -6.52644602536344
Revenue growth (%): -40.09634982397628
Rule of 40 score: -46.622795849339724
Financial ratios for KSS — quarterly report dated 2025-07-31
Total revenue: 3546000000
Gross profit: 1535000000
Operating income: 161000000
Net income: 153000000
Capital expenditures: 90000000
Operating cash flow: 598000000
Depreciation & amortization: 175000000
Net tangible assets: 3927000000
Owner earnings: 238000000
Return on net tangible assets (%): 6.0606060606060606
Capex to operating income (%): 55.90062111801242
Buffett classification: The Good
Stock price: 10.51
P/E ratio: 6.40770928188172
Shares outstanding: 113399993
Book value: 3927000000
P/B ratio: 0.30349730746880565
Market cap (USD): 1191833926.43
Debt to equity: 1.7458619811560987
Current ratio: 1.3634222919937207
Quick ratio: 0.18838304552590268
Effective tax rate (%): 23.88059701492537
Interest coverage ratio: 2.0641025641025643
COGS to revenue (%): 56.711787930062044
SG&A to revenue (%): 33.81274675690919
Free cash flow (dilution-adjusted): 500000000
Buyback yield (%): 0
Retained earnings: 1119000000
Inventory turnover: 0.6716766867067469
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4848289218850872
FCF margin (%): 14.10039481105471
Revenue growth (%): 9.68141045468605
Rule of 40 score: 23.781805265740758